Happy Birthday BNP

Overview

Journal Eur Heart J Acute Cardiovasc Care

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2013 Sep 25

PMID 24062896

Authors

Christian Mueller

Affiliations

Soon will be listed here.

References

Lam L, Cameron P, Schneider H, Abramson M, Muller C, Krum H . Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting. Ann Intern Med. 2010; 153(11):728-35. DOI: 10.7326/0003-4819-153-11-201012070-00006. View

Potocki M, Breidthardt T, Reichlin T, Hartwiger S, Morgenthaler N, Bergmann A . Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure. J Intern Med. 2009; 267(1):119-29. DOI: 10.1111/j.1365-2796.2009.02135.x. View

Breidthardt T, Laule K, Strohmeyer A, Schindler C, Meier S, Fischer M . Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea. Clin Chem. 2007; 53(8):1415-22. DOI: 10.1373/clinchem.2006.081448. View

Kucher N, Printzen G, Doernhoefer T, Windecker S, Meier B, Hess O . Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation. 2003; 107(12):1576-8. DOI: 10.1161/01.CIR.0000064898.51892.09. View

Kucher N, Printzen G, Goldhaber S . Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation. 2003; 107(20):2545-7. DOI: 10.1161/01.CIR.0000074039.45523.BE. View

Mueller C, Laule-Kilian K, Schindler C, Klima T, Frana B, Rodriguez D . Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med. 2006; 166(10):1081-7. DOI: 10.1001/archinte.166.10.1081. View

McCullough P, Nowak R, McCord J, Hollander J, Herrmann H, Steg P . B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002; 106(4):416-22. DOI: 10.1161/01.cir.0000025242.79963.4c. View

Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P . Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004; 350(7):647-54. DOI: 10.1056/NEJMoa031681. View

Rutten J, Steyerberg E, Boomsma F, van Saase J, Deckers J, Hoogsteden H . N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome. Am Heart J. 2008; 156(1):71-7. DOI: 10.1016/j.ahj.2008.02.021. View

10.

Schneider H, Lam L, Lokuge A, Krum H, Naughton M, de Villiers Smit P . B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial. Ann Intern Med. 2009; 150(6):365-71. DOI: 10.7326/0003-4819-150-6-200903170-00004. View

11.

Meisel S, Januzzi J, Medvedovski M, Sharist M, Shochat M, Ashkar J . Pre-admission NT-proBNP improves diagnostic yield and risk stratification - the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study. Eur Heart J Acute Cardiovasc Care. 2013; 1(2):99-108. PMC: 3760533. DOI: 10.1177/2048872612447049. View

12.

Felker G, Hasselblad V, Hernandez A, OConnor C . Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J. 2009; 158(3):422-30. DOI: 10.1016/j.ahj.2009.06.018. View

13.

Davis M, Espiner E, Richards G, Billings J, Town I, Neill A . Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet. 1994; 343(8895):440-4. DOI: 10.1016/s0140-6736(94)92690-5. View

14.

Lainchbury J, Campbell E, Frampton C, Yandle T, Nicholls M, Richards A . Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol. 2003; 42(4):728-35. DOI: 10.1016/s0735-1097(03)00787-3. View

15.

Maisel A, Krishnaswamy P, Nowak R, McCord J, Hollander J, Duc P . Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002; 347(3):161-7. DOI: 10.1056/NEJMoa020233. View

16.

de Lemos J, Morrow D, Bentley J, Omland T, Sabatine M, McCabe C . The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001; 345(14):1014-21. DOI: 10.1056/NEJMoa011053. View

17.

Maisel A, Mueller C, Nowak R, Peacock W, Landsberg J, Ponikowski P . Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010; 55(19):2062-76. DOI: 10.1016/j.jacc.2010.02.025. View

18.

Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M . Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J. 2011; 33(16):2001-6. DOI: 10.1093/eurheartj/ehq509. View

19.

Januzzi J, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M . NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2005; 27(3):330-7. DOI: 10.1093/eurheartj/ehi631. View

20.

Moe G, Howlett J, Januzzi J, Zowall H . N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007; 115(24):3103-10. DOI: 10.1161/CIRCULATIONAHA.106.666255. View